News Conference News EAS 2023 Multipronged Outreach to Families Can Boost FH Cascade Screening: IMPACT-FH Michael O'Riordan May 26, 2023
News Conference News EAS 2022 Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level Michael O'Riordan May 24, 2022
News Conference News ACC 2020 Icosapent Ethyl’s CV Benefit Closely Tied to Serum EPA Levels: REDUCE-IT Todd Neale April 02, 2020
News Conference News ACC 2020 Genotype-Based P2Y12 Prescribing Post-PCI Falls Short in TAILOR-PCI Yael L. Maxwell March 28, 2020
News Conference News ESC 2019 Another Step Forward for Genotype-Guided Prescribing After PCI: POPular Genetics Yael L. Maxwell September 03, 2019
News Conference News ACC 2018 Loading Dose Smooths Switch From Ticagrelor to Clopidogrel After PCI: SWAP-4 Yael L. Maxwell March 19, 2018
News Conference News ACC 2018 Genetic Testing Influences Post-PCI Antiplatelet Prescriptions, but Other Factors Also Play a Role Yael L. Maxwell March 11, 2018
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Conference News ACC 2016 Statin Intolerance and FH: GAUSS-3 Finds Benefit With Evolocumab, While Another Study Exposes Lifetime Risks of FH Michael O'Riordan April 03, 2016
News Conference News GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing August 30, 2011